Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-03

FDA Approved: CIPROFLOXACIN AND DEXAMETHASONE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for ciprofloxacin and dexamethasone, an otic antibiotic/steroid combination. The submission was filed by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin and dexamethasone otic suspension (Ciprofloxacin and dexamethasone)

Snippet

SUPPL AP for CIPROFLOXACIN AND DEXAMETHASONE (CIPROFLOXACIN AND DEXAMETHASONE)